Cosima T Baldari
Overview
Explore the profile of Cosima T Baldari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
4109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pongcharoen S, Spurkland A, Baldari C
Front Immunol
. 2023 Aug;
14:1243039.
PMID: 37564638
No abstract available.
12.
Baldari C, Valitutti S, Dustin M
Front Immunol
. 2023 Jun;
14:1226870.
PMID: 37325629
No abstract available.
13.
Baldari C, Onnis A, Andreano E, Del Giudice G, Rappuoli R
Trends Immunol
. 2023 May;
44(6):424-434.
PMID: 37137805
The COVID-19 pandemic, caused by SARS-CoV-2, has caused an estimated 5 billion infections and 20 million deaths by respiratory failure. In addition to the respiratory disease, SARS-CoV-2 infection has been...
14.
Capitani N, Cassioli C, Ravichandran K, Baldari C
Methods Mol Biol
. 2023 Apr;
2654:421-436.
PMID: 37106198
The Retention Using Selective Hooks (RUSH) system allows for the synchronized release of one or more proteins of interest from a donor endomembrane compartment, usually the endoplasmic reticulum, and the...
15.
Cassioli C, Patrussi L, Valitutti S, Baldari C
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430728
Chimeric antigen receptor (CAR) T cell immunotherapy is a revolutionary pillar in cancer treatment. Clinical experience has shown remarkable successes in the treatment of certain hematological malignancies but only limited...
16.
Onnis A, Andreano E, Cassioli C, Finetti F, Della Bella C, Staufer O, et al.
J Exp Med
. 2022 Nov;
220(2).
PMID: 36378226
CTL-mediated killing of virally infected or malignant cells is orchestrated at the immune synapse (IS). We hypothesized that SARS-CoV-2 may target lytic IS assembly to escape elimination. We show that...
17.
Finetti F, Onnis A, Baldari C
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36292997
Initially discovered as the smallest component of the intraflagellar transport (IFT) system, the IFT20 protein has been found to be implicated in several unconventional mechanisms beyond its essential role in...
18.
Capitani N, Baldari C
Front Immunol
. 2022 Aug;
13:943344.
PMID: 35911720
Similar to other pathogens, bacteria have developed during their evolution a variety of mechanisms to overcome both innate and acquired immunity, accounting for their ability to cause disease or chronic...
19.
Tatangelo V, Boncompagni G, Capitani N, Lopresti L, Manganaro N, Frezzato F, et al.
Front Oncol
. 2022 Jul;
12:877495.
PMID: 35847884
The microenvironment of lymphoid organs is central to the pathogenesis of chronic lymphocytic leukemia (CLL). Within it, tumor cells find a favourable niche to escape immunosurveillance and acquire pro-survival signals....
20.
Federico S, Khan T, Fontana A, Brogi S, Benedetti R, Sarno F, et al.
Eur J Med Chem
. 2022 May;
238:114409.
PMID: 35551034
The search of new therapeutic tools for the treatment of cancer is being a challenge for medicinal chemists. Due to their role in different pathological conditions, histone deacetylase (HDAC) enzymes...